Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration from real-life experience in Italy

被引:0
作者
Asero, Riccardo [1 ]
机构
[1] Clin San Carlo, Ambulatorio Allergol, Milan, Italy
关键词
D O I
10.1080/09546634.2018.1557886
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 14 条
[1]   Outcomes of using omalizumab for more than 1 year in refractory chronic urticaria [J].
Har, Daniel ;
Patel, Saurin ;
Khan, David A. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (02) :126-129
[2]   Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria [J].
Kaplan, Allen ;
Ferrer, Marta ;
Bernstein, Jonathan A. ;
Antonova, Evgeniya ;
Trzaskoma, Benjamin ;
Raimundo, Karina ;
Rosen, Karin ;
Omachi, Theodore A. ;
Khalil, Sam ;
Zazzali, James L. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) :474-481
[3]   Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy [J].
Kaplan, Allen ;
Ledford, Dennis ;
Ashby, Mark ;
Canvin, Janice ;
Zazzali, James L. ;
Conner, Edward ;
Veith, Joachim ;
Kamath, Nikhil ;
Staubach, Petra ;
Jakob, Thilo ;
Stirling, Robert G. ;
Kuna, Piotr ;
Berger, William ;
Maurer, Marcus ;
Rosen, Karin .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (01) :101-109
[4]   Treatment of chronic autoimmune urticaria with omalizumab [J].
Kaplan, Allen P. ;
Joseph, Kusumam ;
Maykut, Robert J. ;
Geba, Gregory P. ;
Zeldin, Robert K. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :569-573
[5]   Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations [J].
Kaplan, Allen P. .
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (06) :477-482
[6]  
Marzano AV, 2018, J EUR ACAD DERMATOL
[7]   The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria [J].
Maurer, Marcus ;
Kaplan, Allen ;
Rosen, Karin ;
Holden, Michael ;
Iqbal, Ahmar ;
Trzaskoma, Benjamin L. ;
Yang, Ming ;
Casale, Thomas B. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (03) :1138-+
[8]   Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria [J].
Maurer, Marcus ;
Rosen, Karin ;
Hsieh, Hsin-Ju ;
Saini, Sarbjit ;
Grattan, Clive ;
Gimenez-Arnau, Ana ;
Agarwal, Sunil ;
Doyle, Ramona ;
Canvin, Janice ;
Kaplan, Allen ;
Casale, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :924-935
[9]   Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study [J].
Saini, Sarbjit S. ;
Bindslev-Jensen, Carsten ;
Maurer, Marcus ;
Grob, Jean-Jacques ;
Baskan, Emel Bulbul ;
Bradley, Mary S. ;
Canvin, Janice ;
Rahmaoui, Abdelkader ;
Georgiou, Panayiotis ;
Alpan, Oral ;
Spector, Sheldon ;
Rosen, Karin .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (01) :67-75
[10]   Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria [J].
Straesser, Matthew D. ;
Oliver, Eric ;
Palacios, Thamiris ;
Kyin, Timothy ;
Patrie, James ;
Borish, Larry ;
Saini, Sarbjit S. ;
Lawrence, Monica G. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (04) :1386-+